Learn more

GDANSKI UNIV MEDYCZNY

Overview
  • Total Patents
    48
  • GoodIP Patent Rank
    42,647
  • Filing trend
    ⇧ 62.0%
About

GDANSKI UNIV MEDYCZNY has a total of 48 patent applications. It increased the IP activity by 62.0%. Its first patent ever was published in 2009. It filed its patents most often in Poland, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CHANGCHUN WAN CHENG BIO ELECTRON CO LTD, VERENIGING HET NL KANKER I and INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE.

Patent filings in countries

World map showing GDANSKI UNIV MEDYCZNYs patent filings in countries

Patent filings per year

Chart showing GDANSKI UNIV MEDYCZNYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jassem Jacek 7
#2 Trzonkowski Piotr 7
#3 Mysliwiec Malgorzata 6
#4 Marek-Trzonkowska Natalia 6
#5 Skrzypski Marcin 5
#6 Bączek Tomasz 5
#7 Rutkowska Aleksandra 4
#8 Konieczna Lucyna 4
#9 Kowalski Piotr 3
#10 Urban Aleksandra 3

Latest patents

Publication Filing date Title
PL430932A1 Method of obtaining in vitro antigen-specific regulatory T lymphocytes
PL427914A1 Breathing phase detector
PL427652A1 Arrangement of a heart valve component, method of producing modified bacterial cellulose (BC), a set and cardiac surgery application of the component
PL427603A1 STAT5A, STAT5B, STAT6 proteins as a molecular target in the treatment of basal cell carcinoma
PL427323A1 Method of analysing polar and thermally unstable compounds using gas chromatography
PL425847A1 New dye for fluorescent dyeing of horny layer of epidermis (stratum corneum), method for obtaining it and its application in microscopy, including for identification of ways of penetration into skin and evaluation of structural disorders of that layer
PL425133A1 Point mutants of B-factor and C2 protein, method for increasing activity of anti-tumor antibodies, pharmaceutical composition and application of mutants
WO2018174733A1 Method for determining bisphenol a in biological material, diagnostic device for detection of bisphenol a in biological material, diagnostic kit for detection of bisphenol a in biological material
PL424955A1 Method for determination of bisphenol A in biological material and the diagnostic device for detection of bisphenol A in biological material, preferably in blood
EP3559675A1 A method for monitoring of amino acids in biological material
PL423176A1 Method for determination of amino acids in the process of acute lymphoblastic leukaemia through monitoring them in the non-invasive collected condensates of the breathed air
PL422788A1 Method for insulation of biogenic amines from biological material
PL420935A1 Diagnostic kit for detection of bisphenol A (BPA) in biological material
PL419960A1 Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids
PL415351A1 Method of in-vitro multiplication of regulatory T cells (Treg)
PL415250A1 Diagnostic test for identification of pathogenic potential of a strain of Enterococcus genus
PL406987A1 Profile of blood protein markers as the test for detecting lung cancer
PL394921A1 New markers and method for predicting the risk of distant recurrence of non small cell carcinoma of the lung in I-III A patients
PL393586A1 Method for testing immunomodulatory properties of substances, especially medicinal substances
PL212748B1 Method for determining the risk of distant recurrence of non small cell lung cancer in patients in I-III A stage treated surgically